Antimicrobial compounds, compositions, and uses thereof
Abstract
Antimicrobial compounds and compositions of Formulas (I) to (III) and methods of use are disclosed. Another aspect of the present disclosure provides a pharmaceutical composition comprising a compound according to Formula (I) to (III), or a pharmaceutically acceptable salt thereof, and one or more pharmaceutically acceptable carriers, excipients, or diluents. Another aspect of the present disclosure provides a method of treating a bacterial infection in a patient in need thereof, the method of comprising administering an effective amount of a compound according to Formula (I) to (III), or a pharmaceutically acceptable salt thereof, to the patient.
Claims
exact text as granted — not AI-modified1 . A compound having the formula:
wherein:
A is a monocyclic, bicyclic, or tricyclic carbocyclic or heterocyclic moiety, and
R 1 and R 2 are each a C 1 -C 8 alkyl moiety; or
a pharmaceutically acceptable salt thereof.
2 . The compound according to claim 1 , wherein R 1 and R 2 are both butyl.
3 . A compound having the formula:
wherein:
Q is oxygen or sulfur;
W is an amino-substituted or guanidino-substituted nitrogen containing heterocyclic moiety;
X and Z are end blocking groups; and
A is H, alkyl, halogen, alkoxy, alkyl-(O-alkyl), aryl, alkenyl, alkanol or phenol.
4 . A compound selected from any one of Cmpds 1 to 2,520 as described in TABLE 1.
5 . A compound having the formula:
or a pharmaceutically acceptable salt thereof.
6 . A pharmaceutical composition comprising a compound according to claim 1 , or a pharmaceutically acceptable salt thereof, and one or more pharmaceutically acceptable carriers, excipients, or diluents.
7 . A method of treating an infection of a diabetic foot ulcer in a patient in need thereof, the method comprising administering an effective amount of a compound according to claim 1 , or a pharmaceutically acceptable salt thereof, to the patient.
8 . A method of treating a complicated urinary tract infection in a patient in need thereof, the method comprising administering an effective amount of a compound according to claim 1 , or a pharmaceutically acceptable salt thereof, to the patient.
9 . A method of treating a lung infection arising from cystic fibrosis in a patient in need thereof, the method comprising administering an effective amount of a compound according to claim 1 , or a pharmaceutically acceptable salt thereof, to the patient.
10 . A method of treating ventilator acquired pneumonia in a patient in need thereof, the method comprising administering an effective amount of a compound according to claim 1 , or a pharmaceutically acceptable salt thereof, to the patient.
11 . A method of treating an infection in a burn wound in a patient in need thereof, the method comprising administering an effective amount of a compound according to claim 1 , or a pharmaceutically acceptable salt thereof, to the patient.
12 . A method of treating otitis externa in a patient in need thereof, the method comprising administering an effective amount of a compound according to claim 1 , or a pharmaceutically acceptable salt thereof, to the patient.
13 . A method of treating bacterial vaginosis in a patient in need thereof, the method comprising administering an effective amount of a compound according to claim 1 , or a pharmaceutically acceptable salt thereof, to the patient.
14 . A method of treating impetigo in a patient in need thereof, the method comprising administering an effective amount of a compound according to claim 1 , or a pharmaceutically acceptable salt thereof, to the patient.
15 . (canceled)
16 . (canceled)
17 . A method of treating an infection in a patient in need thereof, the method comprising administering an effective amount of a compound according to claim 1 , or a pharmaceutically acceptable salt thereof, to the patient.
18 . A method of treating a bladder infection in a patient in need thereof, the method comprising administering an effective amount of a compound according to claim 1 , or a pharmaceutically acceptable salt thereof, to the patient.Join the waitlist — get patent alerts
Track US2021139522A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.